Skip to main content Skip to search Skip to main navigation

What has to be considered for risk management?

Risk management is carried out in 2 stages: first, it is examined whether and how the identified risks can be reduced or eliminated. Then it must be decided whether the remaining residual risks are acceptable. At this stage of the QRM process, it is important on the one hand to keep a sense of proportion between effort and benefit. On the other hand, QRM must not be misused to "discuss away" existing risks.

[GMP Compliance Adviser, Chapter 19.C]

Would you like to discover more?

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business. 

The demo access is non-binding and ends automatically.

Test it now for free

You may also be interested in the following articles:

What is a gas?

What is a gas?

You can view the answer here:
Read more
EDQM: New Ph. Eur. Chapter on Data Quality with a Focus on Digital Data

EDQM: New Ph. Eur. Chapter on Data Quality with a Focus on Digital Data

The European Pharmacopoeia (Ph. Eur.) has introduced a new general chapter that provides a framework for managing the quality of data, including digital data, throughout its life cycle.

Read more
EMA: Pilot Programme for Breakthrough Devices

EMA: Pilot Programme for Breakthrough Devices

The EMA plans to launch a pilot programme in Q2 2026 to implement the guidance for breakthrough devices issued in December 2025.

Read more
Previous
Next